These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35434848)

  • 61. Serum lipids are novel predictors for thyroid autoimmunity in the general population with normal TSH levels from a cross-sectional study.
    Li J; Wang Z; Liu H; Fu J; Qin F; Guan H; Wang W
    Endocrine; 2021 Aug; 73(2):331-338. PubMed ID: 33961194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
    Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
    Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An Inverse Relationship Between Iodine Intake and Thyroid Antibodies: A National Cross-Sectional Survey in Mainland China.
    Teng D; Yang W; Shi X; Li Y; Ba J; Chen B; Du J; He L; Lai X; Li Y; Chi H; Liao E; Liu C; Liu L; Qin G; Qin Y; Quan H; Shi B; Sun H; Tang X; Tong N; Wang G; Zhang JA; Wang Y; Xue Y; Yan L; Yang J; Yang L; Yao Y; Ye Z; Zhang Q; Zhang L; Zhu J; Zhu M; Shan Z; Teng W
    Thyroid; 2020 Nov; 30(11):1656-1665. PubMed ID: 32586221
    [No Abstract]   [Full Text] [Related]  

  • 65. Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents.
    Lawlor DA; Callaway M; Macdonald-Wallis C; Anderson E; Fraser A; Howe LD; Day C; Sattar N
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E410-7. PubMed ID: 24471572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population: A Cross-Sectional Study.
    Guo YC; Zhou Y; Gao X; Yao Y; Geng B; Cui QH; Yang JC; Hu HP
    Chin Med J (Engl); 2018 Oct; 131(19):2269-2276. PubMed ID: 30246712
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease.
    Kim Y; Han E; Lee JS; Lee HW; Kim BK; Kim MK; Kim HS; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Lee YH; Kim SU
    Gut Liver; 2022 Mar; 16(2):290-299. PubMed ID: 34238770
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan.
    Kim D; Konyn P; Cholankeril G; Ahmed A
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1438-e1455. PubMed ID: 34214678
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
    Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
    BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
    Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases.
    Weinberg EM; Trinh HN; Firpi RJ; Bhamidimarri KR; Klein S; Durlam J; Watkins S; Reddy KR; Weiss M; Zink RC; Lok AS
    Clin Gastroenterol Hepatol; 2021 May; 19(5):996-1008.e6. PubMed ID: 32629123
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease.
    Pulixi EA; Tobaldini E; Battezzati PM; D'Ingianna P; Borroni V; Fracanzani AL; Maggioni M; Pelusi S; Bulgheroni M; Zuin M; Fargion S; Montano N; Valenti L
    PLoS One; 2014; 9(4):e96349. PubMed ID: 24763757
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship Between Handgrip Strength and Nonalcoholic Fatty Liver Disease: Nationwide Surveys.
    Lee K
    Metab Syndr Relat Disord; 2018 Nov; 16(9):497-503. PubMed ID: 30129816
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.
    Dogan S; Celikbilek M; Yilmaz YK; Sarikaya S; Zararsiz G; Serin HI; Borekci E; Akyol L; Pirti I; Davarci SE
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):298-304. PubMed ID: 25629574
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.
    Blomdahl J; Nasr P; Ekstedt M; Kechagias S
    Metabolism; 2021 Feb; 115():154439. PubMed ID: 33246008
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    Kang MK; Park JG; Lee HJ; Kim MC
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1633-1640. PubMed ID: 30667551
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association Between Non-Alcoholic Fatty Liver Disease and Diabetes-Related Microvascular Complications: A Retrospective Cross-Sectional Study of Hospitalized Patients.
    Wen X; Zhou X; Chen D; Cheng J; Ji L
    Endocr Pract; 2022 Mar; 28(3):304-309. PubMed ID: 33601024
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones.
    Chou YT; Li CH; Sun ZJ; Shen WC; Yang YC; Lu FH; Chang CJ; Wu JS
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33799865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.